PDF herunterladen
Semin Respir Crit Care Med 2016; 37(02): 303-317
DOI: 10.1055/s-0036-1572561
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Critical Care in Human Immunodeficiency Virus–Infected Patients

Autoren

  • Kathleen M. Akgün

    1   Section of Pulmonary, Critical Care and Sleep, Department of Medicine, VA Connecticut, West Haven, CT
    2   Section of Pulmonary, Critical Care and Sleep, Yale University School of Medicine, New Haven, CT

  • Robert F. Miller

    3   Research Department of Infection and Population Health, University College London, London, United Kingdom
    4   Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
14. März 2016 (online)

   Lizenzen und Reprints

Abstract

Intensive care unit (ICU) survival has been improved significantly for HIV-infected patients since the advent of antiretroviral therapy (ART). Non-AIDS conditions account for the majority of ICU admission diagnoses in areas with access to ART. However, opportunistic infections such as Pneumocystis jirovecii pneumonia still account for a significant proportion of ICU admissions, particularly in newly diagnosed HIV-infected patients, and are associated with increased ICU mortality. We discuss risk factors and outcomes for HIV-infected admitted to the ICU in the current ART era. We review the changing patterns in ICU admission diagnoses over time and how common ICU conditions are managed in HIV-infected compared with uninfected patients. We next address issues specific to the care for HIV-infected patients in the ICU, focusing on immune reconstitution inflammatory syndrome, ART continuation or initiation, and some common and potentially life-threatening ART-associated toxicities.

Keywords

HIV - antiretroviral therapy - outcomes - opportunistic infections